UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 663

Sortiert nach

The microbiome extends host evolutionary potential

Nature communications, 2021-08, Vol.12 (1), p.5141-5141, Article 5141

2021

Link zum Volltext

Verfügbarkeit prüfen

Accounting for genetic interactions improves modeling of individual quantitative trait phenotypes in yeast

Nature genetics, 2017-04, Vol.49 (4), p.497-503

2017

Link zum Volltext

Verfügbarkeit prüfen

Natural CMT2 variation is associated with genome-wide methylation changes and temperature seasonality

PLoS genetics, 2014-12, Vol.10 (12), p.e1004842-e1004842

2014

Link zum Volltext

Verfügbarkeit prüfen

The Multi-allelic Genetic Architecture of a Variance-Heterogeneity Locus for Molybdenum Concentration in Leaves Acts as a Source of Unexplained Additive Genetic Variance

PLoS genetics, 2015-11, Vol.11 (11), p.e1005648-e1005648

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation

Nature communications, 2023, Vol.14 (1), p.7680-7680, Article 7680

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study

Journal of viral hepatitis, 2010-07, Vol.17 (7), p.459-468

2010

Link zum Volltext

Verfügbarkeit prüfen

Genetic Regulation of Transcriptional Variation in Natural Arabidopsis thaliana Accessions

G3 : genes - genomes - genetics, 2016, Vol.6 (8), p.2319-2328

2016

Link zum Volltext

Verfügbarkeit prüfen

Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

Journal of viral hepatitis, 2011-04, Vol.18 (4), p.e81-e90

2011

Link zum Volltext

Verfügbarkeit prüfen

On the relationship between epistasis and genetic variance heterogeneity

Journal of experimental botany, 2017-11, Vol.68 (20), p.5431-5438

2017

Link zum Volltext

Verfügbarkeit prüfen

S3 guideline hepatitis C addendum

Zeitschrift fur Gastroenterologie, 2015-04, Vol.53 (4), p.320

2015

Link zum Volltext

Verfügbarkeit prüfen

High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (9), p.1288-1295

2018

Link zum Volltext

Verfügbarkeit prüfen

Natural selection for imprecise vertical transmission in host-microbiota systems

Nature ecology & evolution, 2022-01, Vol.6 (1), p.77

2022

Link zum Volltext

Verfügbarkeit prüfen

On the Relationship Between High-Order Linkage Disequilibrium and Epistasis

G3 : genes - genomes - genetics, 2018-08, Vol.8 (8), p.2817-2824

2018

Link zum Volltext

Verfügbarkeit prüfen

cgmisc: enhanced genome-wide association analyses and visualization

Bioinformatics (Oxford, England), 2015-12, Vol.31 (23), p.3830-3831

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of the 6 million viral load cut-off to guide treatment duration with ledipasvir/sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection: results from the German Hepatitis C-Registry (DHC-R)

Journal of hepatology, 2017, Vol.66 (1), p.S519-S520

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up after IFN-free therapy of advanced HCV-associated liver cirrhosis: continued improvement of liver function parameters – Results from the German Hepatitis C-Registry (DHC-R)

Journal of hepatology, 2017, Vol.66 (1), p.S55-S55

2017

Link zum Volltext

Verfügbarkeit prüfen

P0777 : Sofosbuvir-based treatment under real life conditions in Germany (The sofger trial)

Journal of hepatology, 2015-04, Vol.62, p.S622-S622

2015

Link zum Volltext

Verfügbarkeit prüfen

Ledipasvir/Sofosbuvir Treatment for 8 Weeks in Treatment-Naïve HCV Genotype 1 Infected Patients under Real Life Conditions: Data from the German Hepatitis C-Registry (DHC-R)

Journal of hepatology, 2016, Vol.64 (2), p.S810-S810

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of IFN- Free Antiviral Therapies in Advanced HCV- Associated Liver Cirrhosis: Results from the German Hepatitis C-Registry (DHC-R)

Journal of hepatology, 2016, Vol.64 (2), p.S787-S787

2016

Link zum Volltext

Verfügbarkeit prüfen

Parameters Associated with Treatment Failure with Direct Acting Antivirals against the Hepatitis C Virus (HCV) – Results Fro the German Hepatitis C Cohort (GECCO)

Journal of hepatology, 2016, Vol.64 (2), p.S808-S809

2016

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of DAA Combination Therapies for Treatment of HCV in Elderly Patients (>70 Yrs): Results from the German Hepatitis C-Registry

Journal of hepatology, 2016, Vol.64 (2), p.S824-S825

2016

Link zum Volltext

Verfügbarkeit prüfen

O119 : Stopping tenofovir disoproxil fumarate (TDF) treatment after long term virologic suppression in HBeAg-negative CHB: Week 48 interim results from an ongoing randomized, controlled trial (“finite CHB”)

Journal of hepatology, 2015-04, Vol.62, p.S253-S253

2015

Link zum Volltext

Verfügbarkeit prüfen

P1141 SUSTAINED VIROLOGICAL RESPONSE (SVR) IN HCV TREATMENT-EXPERIENCED PATIENTS AFTER TRIPLE THERAPY WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN IN A REAL-LIFE SETTING

Journal of hepatology, 2014-04, Vol.60 (1), p.S462-S463

2014

Link zum Volltext

Verfügbarkeit prüfen

872 SUBSTANTIAL RENAL IMPAIRMENT IS NOT INFREQUENT IN HCV PATIENTS UNDER TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR

Journal of hepatology, 2013-04, Vol.58, p.S358-S358

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 663

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(584)
Mit Volltextzugriff
(582)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(462)
Life Sciences & Biomedicine
(278)
Humans
(185)
Physical Sciences
(162)
Female
(127)
Biological And Medical Sciences
(125)
Male
(110)
Chemistry
(90)
Medical Sciences
(86)
Animals
(81)
Middle Aged
(76)
Exact Sciences And Technology
(75)
Adult
(72)
Technology
(67)
Physics
(61)
Aged
(54)
Astronomy & Astrophysics
(42)
Chemistry, Physical
(42)
Fundamental And Applied Biological Sciences. Psychology
(41)
Medicin Och Hälsovetenskap
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The microbiome extends host evolutionary potential

Accounting for genetic interactions improves modeling of individual quantitative trait phenotypes in yeast

Natural CMT2 variation is associated with genome-wide methylation changes and temperature seasonality

The Multi-allelic Genetic Architecture of a Variance-Heterogeneity Locus for Molybdenum Concentration in Leaves Acts as a Source of Unexplained Additive Genetic Variance

Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation

Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study

Genetic Regulation of Transcriptional Variation in Natural Arabidopsis thaliana Accessions

Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

On the relationship between epistasis and genetic variance heterogeneity

The Shepherds' Tale: A Genome-Wide Study across 9 Dog Breeds Implicates Two Loci in the Regulation of Fructosamine Serum Concentration in Belgian Shepherds

S3 guideline hepatitis C addendum

High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection

Natural selection for imprecise vertical transmission in host-microbiota systems

On the Relationship Between High-Order Linkage Disequilibrium and Epistasis

cgmisc: enhanced genome-wide association analyses and visualization

Use of the 6 million viral load cut-off to guide treatment duration with ledipasvir/sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection: results from the German Hepatitis C-Registry (DHC-R)

Long-term follow-up after IFN-free therapy of advanced HCV-associated liver cirrhosis: continued improvement of liver function parameters – Results from the German Hepatitis C-Registry (DHC-R)

P0777 : Sofosbuvir-based treatment under real life conditions in Germany (The sofger trial)

Ledipasvir/Sofosbuvir Treatment for 8 Weeks in Treatment-Naïve HCV Genotype 1 Infected Patients under Real Life Conditions: Data from the German Hepatitis C-Registry (DHC-R)

Safety and Efficacy of IFN- Free Antiviral Therapies in Advanced HCV- Associated Liver Cirrhosis: Results from the German Hepatitis C-Registry (DHC-R)

Parameters Associated with Treatment Failure with Direct Acting Antivirals against the Hepatitis C Virus (HCV) – Results Fro the German Hepatitis C Cohort (GECCO)

Effectiveness and Safety of DAA Combination Therapies for Treatment of HCV in Elderly Patients (>70 Yrs): Results from the German Hepatitis C-Registry

O119 : Stopping tenofovir disoproxil fumarate (TDF) treatment after long term virologic suppression in HBeAg-negative CHB: Week 48 interim results from an ongoing randomized, controlled trial (“finite CHB”)

P1141 SUSTAINED VIROLOGICAL RESPONSE (SVR) IN HCV TREATMENT-EXPERIENCED PATIENTS AFTER TRIPLE THERAPY WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN IN A REAL-LIFE SETTING

872 SUBSTANTIAL RENAL IMPAIRMENT IS NOT INFREQUENT IN HCV PATIENTS UNDER TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR

Suchergebnisse filtern